Edible Marijuana Labels Wrong

The dosage information on 83 percent of 75 edible marijuana products legally sold in Seattle, San Francisco, and Los Angeles was incorrect.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edible marijuana products, such as these cakes, may contain more or less THC than their labels indicate.WIKIMEDIA, STAS2KIn US states where marijuana has been legalized—either for medicinal or recreational purposes—foods, drinks, and candies containing tetrahydrocannabinol (THC), the psychoactive compound in weed, have become very popular. But buyers beware: in a paper published in the Journal of the American Medical Association yesterday (June 23), researchers show that only 17 percent of 75 the edible medical marijuana products they tested had labels that accurately reported the amount of THC they contained.

Twenty three percent of the products, which were purchased in Seattle, San Francisco, and Los Angeles, contained more THC than their labels reported, and 60 percent contained less. “We need a more accurate picture of what’s being offered to patients,” Donald Abrams, hematology and oncology chief at San Francisco General Hospital who was not involved in the new study, told The New York Times. “What we have now in this country is an unregulated medical marijuana industry, due to conflicts between state and federal laws.” Johns Hopkins University School of Medicine behavioral scientist Ryan Vandrey, who was first author on the study, agreed. “We don’t have the kind of quality assurance for edibles that we have for any other medicine.”

Mislabeling edible cannabis products—consumed by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies